|Articles|February 19, 2016
Therapeutic Innovation & Regulatory Science: An Increasingly Global Approach
Author(s)DIA
Advertisement
A series of contributions emphasizing the increasingly global nature of medical product development and regulation is highlighted in this issue with contributions from around the world. Additional articles on central monitoring, clinical trial outcomes, and data quality are also included.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
2
Reading Between the Lines: Closing the T1D Misdiagnosis Gap
3
Pharmaceutical Executive Daily: FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer
4
The Rise of Direct-to-Patient Models in Pharma: Opportunities and Risks in Bypassing Traditional Distribution Channels
5